Latest news
The Vaccine Group’s African Swine Fever vaccine enters animal trials
African Swine Fever is a highly contagious and devasting disease prevalent worldwide. There is currently no safe and effective vaccine. A vaccine candidate developed The Vaccine Group in collaboration with The Pirbright Institute has now entered animal trials.
Read moreWatch: TVG CEO Jeremy Salt on Syva collaboration and what’s next for the company
The Vaccine Group has entered a collaboration with global animal health group Syva to develop a vaccine against zoonotic pig disease Streptococcus suis. CEO Jeremy Salt discusses the partnership, other vaccine developments and the company’s work on biotherapeutics.
Read moreAnimal health group Syva to collaborate with The Vaccine Group
The Vaccine Group has entered into a collaboration with leading Spanish animal health group Syva to develop a vaccine against Streptococcus suis, an economically damaging and zoonotic pig disease.
Read moreOur portfolio
Our portfolio companies are involved in developing a wide range of technologies based on cutting-edge intellectual property to meet the needs and demands of the world.
See all companiesDekiln
Dekiln, formerly known as DeakinBio, has developed BioSintering®, a technology combining waste materials such as gypsum powder with bio-based active ingredients to produce a revolutionary, low-carbon alternative to traditional ceramic tiles.
Learn moreShare price
Share Price InformationLatest downloads
Half Year Results 2024/25
